Filing Details

Accession Number:
0001179110-14-001871
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-04 17:02:39
Reporting Period:
2014-01-31
Filing Date:
2014-02-04
Accepted Time:
2014-02-04 17:02:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565892 E Robert Funck 100 Abbott Park Road
Abbott Park IL 60064
Vice President, Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2014-01-31 2,137 $31.61 62,365 No 4 M Direct
Common Shares Without Par Value Acquisiton 2014-01-31 5,715 $33.88 68,080 No 4 M Direct
Common Shares Without Par Value Acquisiton 2014-01-31 1,546 $35.08 69,626 No 4 M Direct
Common Shares Without Par Value Disposition 2014-01-31 2,598 $36.19 67,028 No 4 S Direct
Common Shares Without Par Value Disposition 2014-01-31 5,608 $36.20 61,420 No 4 S Direct
Common Shares Without Par Value Disposition 2014-01-31 1,192 $36.21 60,228 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2014-01-31 2,137 $0.00 2,137 $31.61
Common Shares Option (right to buy) Disposition 2014-01-31 5,715 $0.00 5,715 $33.88
Common Shares Option (right to buy) Disposition 2014-01-31 1,546 $0.00 1,546 $35.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-04-27 2014-02-19 No 4 M Direct
0 2013-08-02 2014-02-19 No 4 M Direct
0 2013-08-20 2014-02-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 15,475 Indirect Profit Sharing Trust
Common Shares Without Par Value 500 Indirect By daughter
Common Shares Without Par Value 500 Indirect By daughter
Footnotes
  1. Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2014.
  2. The reporting person disclaims beneficial ownership of all securities held by his daughter.
  3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.